Say you're a woman having a screening mammogram and the radiologist finds something suspicious. But it turns out to be a so-called "false-positive," and not any type of cancer. So you're off the hook. Right? Maybe not, because a new study says that result might have implications for developing cancer at a later time.
One of the toughest decisions currently facing women involves breast cancer screening. When should mammograms begin, and should self-exams or clinical exams by a health provider be embraced? A leading group just posted new guidelines, shedding new light on this important issue.
A recent New York Times op-ed called for universal testing for the BRCA genes among women of Jewish descent, whose ancestry is from eastern Europe. The frighteningly high rate of BRCA positivity and the dire prognosis of such carriers are cited as the primary reasons.
A recent article published online in JAMA Oncology focuses on the increased recent attention in medicine, the media, and by the general public that has generated the perception that rates of breast cancer among young women have been increasing. (An
Disturbing reports about commonly used drugs mean...what? Screening tests over-used, dietary recommendations revamped. In summary: Science Marches On. That s what science is all about, as new data lead to new conclusions for those able to adjust.
October marks breast cancer awareness month, as we pointed out last week. If you follow football, and even if you don t, you may have noticed players, coaches and
It s hard to believe that anyone can not be aware of breast cancer (BC) these days, when the disease, putative causes and varying types of treatments are constantly the news. It s good to remind people, however, that breast cancer is not fully understood, that there may be more than one type, and that while life expectancy post-treatment has been increasing, there is no certain cure.
Drs. Lydia Pace and Nancy Keating of Boston s Brigham and Women s Hospital examined data from studies on mammography, especially the most recent ones. Because breast cancer is the second most common cause of cancer death in American women, and guidelines for mammography use have been changing, they reviewed the data on mammography benefits and harms.
Major study of screening mammography confirms what we have been told, over and over: routine screening for breast cancer saves few (if any) lives and the costs financial, medical and emotional are huge.
Here s another reason why it s important to follow the guidelines issued by the U.S. Preventive Services Task Force (USPSTF) regarding mammography screenings: It could save billions of
According to the American Cancer Society and the National Comprehensive Cancer Network, the use of breast MRI should be limited to those women who have a greater than 20 percent lifetime risk of breast cancer, or for further evaluation of indeterminate lesions. Furthermore, MRI is not recommended for new cancer diagnoses or